Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2020-01-29
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Shared Decision Making in Dialysis
NCT04392440
Seasonal Differences in Home Dialysis Uptake and Initiating Dialysis in the Hospital
NCT04935827
Short Daily Hemodialysis and Online HDF: Which One is Better?
NCT00939445
FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
NCT00288613
Evaluation of a Virtual Home Dialysis Mentoring Program (Home)
NCT04806126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Clinical and psychosocial stabilization: to include lab values, clinical dialysis parameters, patient-reported symptoms, quality of life, hospitalization and mortality rates.
2. Dialysis modality choice with satisfaction with the modality education and continued modality use over 24 months.
3. Patient knowledge, activation, and satisfaction.
4. Program parameters such as time, costs, referral rate, admissions and length of stay within the program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Other
This program, which is provided for all patients new to dialysis at the participating units, will be evaluated by assessing patient clinical outcomes and the results of surveys measuring patient-reported symptoms, quality of life, knowledge and activation. In addition, satisfaction with the program will be assessed.
Analysis using descriptive statistics of patient clinical outcomes.
Evaluation of the following:
* Laboratory values at admission, week 4, and day 90.
* Pre and post blood pressure at week one and week 4.
* Intradialytic hypotension at week one and week 4.
* Ultrafiltration rates at week one, week 4, day 90, day 180, and day 360.
* Target weight defined and achievement in week one and week 4 and changes between week one and week 4.
* Dialysis access type at week one and day 90.
* Hospitalization and mortality rates.
Surveys with participants using validated survey tools.
Surveys will assess participants' Symptom index, Quality of Life, Patient Activation as well as satisfaction with the program.
Evaluation of the program process including time, costs, referral rates, admission to the program and length of stay.
Data will be collected using tracking tools throughout the program.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis using descriptive statistics of patient clinical outcomes.
Evaluation of the following:
* Laboratory values at admission, week 4, and day 90.
* Pre and post blood pressure at week one and week 4.
* Intradialytic hypotension at week one and week 4.
* Ultrafiltration rates at week one, week 4, day 90, day 180, and day 360.
* Target weight defined and achievement in week one and week 4 and changes between week one and week 4.
* Dialysis access type at week one and day 90.
* Hospitalization and mortality rates.
Surveys with participants using validated survey tools.
Surveys will assess participants' Symptom index, Quality of Life, Patient Activation as well as satisfaction with the program.
Evaluation of the program process including time, costs, referral rates, admission to the program and length of stay.
Data will be collected using tracking tools throughout the program.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Without significant cognitive impairment;
* Able to meaningfully interact with staff; and
* Fluent in English (due to education material being limited to English at this time).
Exclusion Criteria
* Unable to read and understand English; or
* Has significant cognitive impairment per the nephrologist or Principal Investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Satellite Healthcare
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wael F Hussein, MBBS
Role: PRINCIPAL_INVESTIGATOR
Satellite Healthcare, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Satellite Healthcare Oakland
Oakland, California, United States
Satellite Healthcare Sacramento
Sacramento, California, United States
Satellite Healthcare Chickasaw Gardens
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SIH124_Optional Transition
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.